Impregnation of Curcumin into a Biodegradable (Poly-lactic-co-glycolic acid, PLGA) Support, to Transfer Its Well Known In Vitro Effect to an In Vivo Prostate Cancer Model.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
29 Sep 2019
Historique:
received: 10 09 2019
revised: 24 09 2019
accepted: 26 09 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 4 3 2020
Statut: epublish

Résumé

Prostate cancer (PCa) is one of the most common cancers in older men and is associated with high mortality. Despite advances in screening for early detection of PCa, a large proportion of patients continue to be diagnosed with metastatic disease, with ~20% of men showing a high tumor grade and stage. Medicinal plant extracts have a great potential to prevent/treat PCa, as well as to reduce its incidence/prevalence and improve survival rates. One of the most promising extracts is curcumin, which is a major, nontoxic, bioactive compound of

Identifiants

pubmed: 31569529
pii: nu11102312
doi: 10.3390/nu11102312
pmc: PMC6835253
pii:
doi:

Substances chimiques

Capsules 0
Plant Extracts 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS
Curcumin IT942ZTH98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : Ramón y Cajal Fellowships RyC-2014-16307

Références

Korean J Urol. 2015 Sep;56(9):656-65
pubmed: 26366279
Am J Transl Res. 2019 Apr 15;11(4):2550-2569
pubmed: 31105862
J Biomed Mater Res B Appl Biomater. 2008 Apr;85(1):196-203
pubmed: 17854066
Biomaterials. 2014 Mar;35(10):3467-79
pubmed: 24439418
Phytother Res. 2018 Jun;32(6):985-995
pubmed: 29480523
BMJ Open. 2019 Jun 22;9(6):e029149
pubmed: 31230029
Macromol Biosci. 2004 Sep 16;4(9):835-64
pubmed: 15468294
Colloids Surf B Biointerfaces. 2014 Feb 1;114:82-8
pubmed: 24176886
Colloids Surf B Biointerfaces. 2019 Aug 1;180:495-502
pubmed: 31103709
Mol Pharm. 2012 Feb 6;9(2):269-80
pubmed: 22136259
Int J Mol Sci. 2019 Apr 18;20(8):
pubmed: 31003422
AIMS Med Sci. 2015;2(4):271-294
pubmed: 26636131
APMIS. 2017 Feb;125(2):134-140
pubmed: 28120490
Front Genet. 2019 Jun 04;10:514
pubmed: 31214247
J Pharm Biomed Anal. 2008 Jan 22;46(2):374-80
pubmed: 17988818
PLoS One. 2015 Jul 24;10(7):e0132609
pubmed: 26208167
Cell Oncol (Dordr). 2019 Aug;42(4):405-421
pubmed: 30980365
Int J Mol Sci. 2019 Mar 01;20(5):
pubmed: 30823649
Planta Med. 1998 May;64(4):353-6
pubmed: 9619120
J Cell Physiol. 2019 Nov;234(11):21126-21134
pubmed: 31037726
J Pharmacol Exp Ther. 2008 Dec;327(3):673-82
pubmed: 18780831
Planta Med. 2017 Mar;83(5):366-381
pubmed: 28178749
AAPS J. 2010 Jun;12(2):223-32
pubmed: 20198462
AAPS J. 2015 Sep;17(5):1065-79
pubmed: 26089090
Pharmazie. 2012 Jun;67(6):518-24
pubmed: 22822540
Chem Biol Interact. 2018 Aug 1;291:228-236
pubmed: 29906455
Pharmacol Res. 2019 Jan;139:91-105
pubmed: 30408575
CA Cancer J Clin. 2019 Sep;69(5):363-385
pubmed: 31184787
Urol Oncol. 2019 Jun;37(6):387-401
pubmed: 29103966
Drug Dev Ind Pharm. 2019 Mar;45(3):365-378
pubmed: 30394795
Prostate. 2015 Sep;75(12):1227-46
pubmed: 26073897
J Colloid Interface Sci. 2010 Nov 1;351(1):19-29
pubmed: 20627257
Int J Mol Sci. 2019 Jun 21;20(12):
pubmed: 31234468
Endocr Regul. 2017 Oct 26;51(4):220-228
pubmed: 29232190
Biochem Pharmacol. 2010 Feb 1;79(3):330-8
pubmed: 19735646
EBioMedicine. 2019 Feb;40:504-516
pubmed: 30692044
Phytomedicine. 2011 Dec 15;19(1):83-7
pubmed: 21802927
Curr Med Chem. 2010;17(3):190-7
pubmed: 20214562
Mol Carcinog. 2016 Jan;55(1):27-39
pubmed: 25559363
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S481-S491
pubmed: 30299174
Semin Cancer Biol. 2016 Oct;40-41:160-169
pubmed: 27370570
Epigenetics. 2019 Dec;14(12):1194-1208
pubmed: 31232159
Biomaterials. 2000 Dec;21(23):2475-90
pubmed: 11055295
Pol Arch Intern Med. 2017 Jan 10;127(1):25-35
pubmed: 28075422
Free Radic Biol Med. 2019 Aug 1;139:24-34
pubmed: 31100478
Biomater Sci. 2018 Mar 26;6(4):827-835
pubmed: 29480308
Curr Cancer Drug Targets. 2014;14(1):70-8
pubmed: 24200079
Cancer Res. 2008 Mar 15;68(6):1962-9
pubmed: 18339878
In Vivo. 2019 Jul-Aug;33(4):983-997
pubmed: 31280187
Breast Cancer Res Treat. 2011 Jul;128(1):97-107
pubmed: 20680677
J Int Med Res. 2019 Mar;47(3):1288-1297
pubmed: 30727807
Molecules. 2018 Nov 15;23(11):
pubmed: 30445746
Oncotarget. 2017 Nov 30;8(67):111225-111245
pubmed: 29340049
PLoS One. 2017 Mar 8;12(3):e0173728
pubmed: 28273144
ACS Biomater Sci Eng. 2018 Feb 12;4(2):694-706
pubmed: 33418757

Auteurs

Eulalio Gracia (E)

Institute of Chemical and Environmental Technology (ITQUIMA), Department of Chemical Engineering, University of Castilla-La Mancha, 13071 Ciudad Real, Spain. Eulalio.Gracia@uclm.es.

Andrea Mancini (A)

Laboratory of Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy. mancio_1982@hotmail.com.

Alessandro Colapietro (A)

Laboratory of Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy. alecolapietro@gmail.com.

Cristina Mateo (C)

Food Technology Lab, School of Architecture, Engineering and Design, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain. cristina.mateo@universidadeuropea.es.

Ignacio Gracia (I)

Institute of Chemical and Environmental Technology (ITQUIMA), Department of Chemical Engineering, University of Castilla-La Mancha, 13071 Ciudad Real, Spain. Ignacio.Gracia@uclm.es.

Claudio Festuccia (C)

Laboratory of Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy. claudio.festuccia@univaq.it.

Manuel Carmona (M)

Food Technology Lab, School of Architecture, Engineering and Design, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain. manuel.carmona@universidadeuropea.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH